S'abonner

Right ventricular dysfunction in acute heart failure from emergency department to discharge: Predictors and clinical implications - 13/01/22

Doi : 10.1016/j.ajem.2021.11.024 
Nicholas E. Harrison, MD MSc a, b, , Robert Ehrman, MD MSc b, Mark Favot, MD b, Laura Gowland b, Jacob Lenning, MD b, Aiden Abidov, MD PhD c, Sarah Henry, PA-C d, Sushane Gupta, MD b, Robert Welch, MD MSc b, Phillip Levy, MD MPH b
a Indiana University School of Medicine, Department of Emergency Medicine, USA 
b Wayne State University School of Medicine, Department of Emergency Medicine, USA 
c Wayne State University School of Medicine, Department of Medicine Section of Cardiology, John D. Dingell VA Medical Center, Section of Cardiology, USA 
d Wayne State University School of Medicine, USA 

Corresponding author at: 720 Eskenazi Avenue, Fifth Third Bank Building 3rd Floor, Indianapolis, IN 46202, USA.720 Eskenazi AvenueFifth Third Bank Building 3rd FloorIndianapolisIN46202USA

Abstract

Background

Among acute heart failure (AHF) inpatients, right ventricular dysfunction (RVD) predicts clinical outcomes independent of left ventricular (LV) dysfunction. Prior studies have not accounted for congestion severity, show conflicting findings on echocardiography (echo) timing, and excluded emergency department (ED) patients. We describe for the first time the epidemiology, predictors, and outcomes of RVD in AHF starting with earliest ED treatment.

Methods

Point-of-care echo and 10-point lung ultrasound (LUS) were obtained in 84 prospectively enrolled AHF patients at two EDs, ≤1 h after first intravenous diuresis, vasodilator, and/or positive pressure ventilation (PPV). Echo and LUS were repeated at 24, 72, and 168 h, unless discharged sooner (n = 197 exams). RVD was defined as <17 mm tricuspid annulus plane systolic excursion (TAPSE), our primary measure. To identify correlates of RVD, a multivariable linear mixed model (LMM) of TAPSE through time was fit. Possible predictors were specified a priori and/or with p ≤ 0.1 difference between patients with/without RVD. Data were standardized and centered to facilitate comparison of relative strength of association between predictors of TAPSE. Survival curves for a 30-day death or AHF readmission primary outcome were assessed for RVD, LUS severity, and LVEF. A multivariable generalized linear mixed model (GLMM) for the outcome was used to adjust RVD for LVEF and LUS.

Results

46% (n = 39) of patients at ED arrival showed RVD by TAPSE (median 18 mm, interquartile range 13–23). 18 variables with p ≤ 0.1 unadjusted difference with/without RVD, and 12 a priori predictors of RVD were included in the multivariable LMM model of TAPSE through time (R2 = 0.76). Missed antihypertensive medication (within 7 days), ED PPV, chronic obstructive pulmonary disease history, LVEF, LUS congestion severity, and right ventricular systolic pressure (RVSP) were the strongest multivariable predictors of RVD, respectively, and the only to reach statistical significance (p < 0.05). 30-day death or AHF readmission was associated with RVD at ED arrival (hazard ratio {HR} 3.31 {95%CI: 1.28–8.53}, p = 0.009), ED to discharge decrease in LUS (HR 0.11 {0.01–0.85}, p < 0.0001 for top quartile Δ), but not LVEF (quartile 2 vs. 1 HR 0.78 {0.22–2.68}, 3 vs. 1 HR 0.55 {0.16–1.92}, 4 vs. 1 HR 0.32 {0.09–1.22}, p = 0.30). The area under the receiver operating curve on GLMM for the primary outcome by TAPSE (p = 0.0012), ΔLUS (p = 0.0005), and LVEF (p = 0.8347) was 0.807.

Conclusion

In this observational study, RVD was common in AHF, and predicted by congestion on LUS, LVEF, RVSP, and comorbidities from ED arrival through discharge. 30-day death or AHF-rehospitalization was associated with RVD at ED arrival and ΔLUS severity, but not LVEF.

Le texte complet de cet article est disponible en PDF.

Keywords : Heart failure, Right ventricular dysfunction, Lung ultrasound, Echocardiography, Emergency medicine, Cardiology

Abbreviations : AHF, HF, ED, RV, RVD, LV, PPV, POC, TAPSE, EF, US, LUS, echo, ACC, ASE, BMI, COPD, OSA, CPAP, PHTN, LOS, GLMM, LMM, VIF, AUROC, 95%CI, RVOT, VTI


Plan


© 2021  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 52

P. 25-33 - février 2022 Retour au numéro
Article précédent Article précédent
  • Choice of intravenous thrombolysis therapy in patients with mild stroke complaining of acute dizziness
  • Tianming Shi, Zheyu Zhang, Bo Jin, Jingwen Wang, Huadong Wu, Junxia Zheng, Xingyue Hu
| Article suivant Article suivant
  • Attitudes among healthcare professionals towards cardiopulmonary resuscitation during COVID-19
  • Safinaz AL-shiakh, Quincy K. Tran, Amy Caggiula, Ivan Berezowski, Basma Barnawi, Ali Pourmand

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.